BrainGate shows early promise in human trial
This article was originally published in Clinica
Cyberkinetics Neurotechnology Systems has reported positive results from preliminary trial of its implantable BrainGate Neural Interface System - a device which aims to convert brain cell impulses into computer signals. The BrainGate system aspires to give paralysed patients the ability to use their thoughts to control a computer interface, so that they can maintain simple communication skills.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.